Cat. No. 3744
Biological ActivityN-terminally extended form of human hemopressin that acts as a selective CB1 receptor agonist. Increases intracellular Ca2+ levels in cells expressing CB1 receptors in vitro.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Certificate of Analysis / Safety Data Sheet
Gomes et al (2009) Novel endogenous peptide agonists of cannabinoid receptors. FASEB J. 23 3020. PMID: 19380512.
If you know of a relevant citation for this product please let us know.
Keywords: RVD-Hpa, supplier, selective, CB1, receptors, agonists, cannabinoids, RVD-Hpalpha, RVD-Hpα, cb1r
Find multiple products by catalog number
New Products in this Area
Potent, high affinity CB1 receptor inverse agonistSR 141716A
Selective CB1 receptor antagonist
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.